New Blood Marker of Endoscopic Disease Activity-A Step Forward in Treating Crohn's Disease to Target?

Gastroenterology. 2020 Feb;158(3):463-465. doi: 10.1053/j.gastro.2019.12.015. Epub 2019 Dec 19.

Authors

Manasi Agrawal¹, Ryan C Ungaro¹, Jean-Frederic Colombel²

Affiliations

¹ The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York.
² The Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: jean-frederic.colombel@mssm.edu.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Crohn Disease*
Endoscopy, Gastrointestinal
Humans

Substances

Biomarkers

Grants and funding

K23 DK111995/DK/NIDDK NIH HHS/United States